Mannitol for the prevention of cisplatin-induced nephrotoxicity: A retrospective comparison of hydration plus mannitol versus hydration alone in inpatient and outpatient regimens at a large academic medical center

Safety of a short hydration method for cisplatin administration in comparison with a conventional method—a retrospective study

(2016) Emiko Sakaida et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Mannitol to prevent cisplatin-induced nephrotoxicity in patients with squamous cell cancer of the head and neck (SCCHN) receiving concurrent therapy

(2015) Trevor McKibbin et al.   SUPPORTIVE CARE IN CANCER

Rates of Renal Toxicity in Cancer Patients Receiving Cisplatin With and Without Mannitol

(2014) Katherine P. Morgan et al.   ANNALS OF PHARMACOTHERAPY

The Role of Mannitol as a Nephroprotectant in Patients Receiving Cisplatin Therapy

(2012) K. P. Morgan et al.   ANNALS OF PHARMACOTHERAPY

A comparison of the rates of cisplatin (cDDP) - induced nephrotoxicity associated with sodium loading or sodium loading with forced diuresis as a preventative measure

(2009) Lily Leu et al.   JOURNAL OF ONCOLOGY PHARMACY PRACTICE

Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies

(2008) N. Pabla et al.   KIDNEY INTERNATIONAL